A randomized controlled trial of reducing calcineurin inhibitor target level by 50% versus converting to rapamycin in chronic kidney allograft dysfunction without reversible causes
|Effective start/end date||5/7/08 → 8/7/16|
- WYETH RESEARCH
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.